-
221.
公开(公告)号:US20200264339A1
公开(公告)日:2020-08-20
申请号:US16866017
申请日:2020-05-04
Inventor: Chang-Koo KIM , Jun-Hyun KIM
IPC: G02B1/11 , H01L31/18 , H01L33/44 , G02B5/02 , G02B1/12 , H01L31/028 , H01L31/0236 , H01L33/46 , H01L31/054
Abstract: The present disclosure provides a structure having a low reflectance surface, wherein the structure comprises: a base plate; and a plurality of inclined rods protruding from a first face of the base plate and inclined relative to a normal line to the first face, wherein the inclined rods are spaced from each other. Travel paths of light beams in the structure may be longer along the inclined rods. As a result, a larger amount of light may be absorbed by the structure having a low reflectance surface. The amount of light-beams as reflected from the structure having a low reflectance surface may be significantly reduced.
-
公开(公告)号:US20200254008A1
公开(公告)日:2020-08-13
申请号:US16643418
申请日:2018-08-23
Inventor: Chul Ho KIM , Sung Un KANG
Abstract: The present invention relates to a method of preventing or treating keloids using a liquid plasma. A liquid plasma according to the present invention is remarkably effective in inhibiting the generation and proliferation of keloids, thus being expected to be greatly utilized for the prevention and treatment of keloids.
-
223.
公开(公告)号:US20200244288A1
公开(公告)日:2020-07-30
申请号:US16637481
申请日:2018-08-08
Inventor: Kwangseok NOH , Bonghoe KIM , Song Nam HONG
Abstract: In a wireless communication system, a transmission device generates (K+J) bits by adding J cyclic redundancy check (CRC) bits to K information bits, and interleaves the (K+J) bits according to a seed value-based interleaving pattern. The transmission device encodes the bits interleaved according to the interleaving pattern, using a polar code. The seed value permutates the CRC bits, and a value previously determined according to K is used as the seed value.
-
224.
公开(公告)号:US20200175340A1
公开(公告)日:2020-06-04
申请号:US16655443
申请日:2019-10-17
Inventor: Jung Won LEE , Ye Seul PARK , Dong Yeon YOO , Chang Nam LIM
Abstract: The present disclosure relates to a method for evaluating quality of a medical image dataset and a system thereof capable of confirming whether medical image data is suitable to be used for machine learning. Evaluation items may include data normality which means a ratio of normal frames in all frames; learning fitness which means a ratio of labeled or labelable frames in the received data; and anatomical completeness which means a ratio of anatomical elements included in the received data against anatomical elements based on medical standards.
-
225.
公开(公告)号:US20200174849A1
公开(公告)日:2020-06-04
申请号:US16509568
申请日:2019-07-12
Inventor: Hoeseok YANG , Hyeonseok JUNG
Abstract: The present disclosure relates to a dataflow optimization method for low-power operation of a multicore system, the dataflow optimization method including: a step (a) of creating an FSM including a plurality of system states in consideration of dynamic factors that trigger a transition in system states for original dataflow; and a step (b) of optimizing the original dataflow through optimization of the created FSM.
-
公开(公告)号:US10666759B2
公开(公告)日:2020-05-26
申请号:US15601469
申请日:2017-05-22
Inventor: Jae Hoon Kim , Myeong Wuk Jang , Yung Bae Ko , Sung Won Lee
IPC: H04L29/08
Abstract: Provided is a communication method of a node overhearing content in a content centric network (CCN) and the node, the communication method including, overhearing a content transmitted from a neighboring node, caching the overheard content, and providing the overheard content, in response to receiving a content request packet requesting the overheard content.
-
公开(公告)号:US10650339B2
公开(公告)日:2020-05-12
申请号:US15603545
申请日:2017-05-24
Inventor: Do Yeong Kim , Jun Su Park , Gyoung Hwan Kim , Keon Ho Kim , Do Won Kim
Abstract: Provided are a method and a server for assessing a debt management competency, which provide a determination reference for inducing and educating an individual to rationally make a decision on a debt redemption by progressing the rounds by the predetermined number of times, selecting a specific debt among the plurality of debts and setting the amount of money to be repaid for the debt in an income for each round, setting an assessment grade for a user according to a debt settlement amount calculated in a final round, and providing a user with feedback information according to an assessment grade.
-
公开(公告)号:US10594387B2
公开(公告)日:2020-03-17
申请号:US15956257
申请日:2018-04-18
Inventor: Ikmo Park , Jaejin Lee , Ta Son Xuat
IPC: H04B7/185 , H02S10/40 , H02S99/00 , H01Q1/36 , H01Q21/26 , H01L31/0475 , H01Q1/28 , H01Q9/04 , H01Q1/44 , H01Q25/00 , H01Q9/06 , H01L31/046 , H01L27/142 , H01Q9/26
Abstract: Disclosed is a solar cell integrated with a radio wave transceiving apparatus. A solar cell integrated with a radio wave transceiving apparatus according to an exemplary embodiment of the present disclosure may include a substrate; a solar cell in which a plurality of unit cells is periodically arranged on the upper surface of the substrate to form a metasurface; and a crossed dipole type radiator positioned on the solar cell.
-
229.
公开(公告)号:US20200022954A1
公开(公告)日:2020-01-23
申请号:US16488881
申请日:2018-03-09
Inventor: Yun-Hoon CHOUNG , Yun Yeong LEE , Oak-Sung CHOO
Abstract: The present invention relates to a composition for preventing or treating hearing loss, containing an HMG-CoA reductase inhibitor and, more specifically, to a composition for preventing or treating diabetes-mediated hearing loss, containing, as an active ingredient(s), one or more types selected from the group consisting of atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin and simvastatin. A pharmaceutical composition containing an HMG-CoA reductase inhibitor, according to the present invention, inhibits auditory cell death caused by diabetes, and thus is very useful as an agent for preventing or treating diabetes-mediated sensorineural hearing loss.
-
公开(公告)号:US10537014B2
公开(公告)日:2020-01-14
申请号:US16335925
申请日:2017-09-19
Inventor: Chul Ho Kim , Sung Un Kang
Abstract: Provided is a composition for obesity treatment comprising a liquid-phase plasma. More particularly, provided is a method for producing a liquid-phase plasma for inhibiting adipocyte differentiation or proliferation, a pharmaceutical composition for obesity prevention or treatment using a liquid-phase plasma produced according to the method, and a method for obesity prevention or treatment using the liquid-phase plasma.
-
-
-
-
-
-
-
-
-